TABLE 4.
Electroconvulsive Therapy Treatment Characteristics
| CARE Network Site | Type of ECT, n (%) | Acute ECT 3×/wk, n (%)* | ||
|---|---|---|---|---|
| 2019 | 2020 | 2019 | 2020 | |
| Site 1 | Bifrontal: 9/25 (36.0) | Bifrontal: 21/21 (100) | 25/25 (100) | 21/21 (100) |
| Bitemporal: 0 | Bitemporal: 0 | |||
| Right unilateral: 1/25 (4.0) | Right unilateral: 0 | |||
| Ultrabrief: 15/25 (60.0) | Ultrabrief: 0 | |||
| Site 2 | Bifrontal: 13/20 (65.0) | Bifrontal: 8/12 (66.7) | 3/20 (15.0) | 5/10 (50.0) |
| Bitemporal: 0 | Bitemporal: 1/12 (8.3) | |||
| Right unilateral: 4/20 (20.0) | Right unilateral: 2/12 (16.7) | |||
| Ultrabrief: 3/20 (15.0) | Ultrabrief: 1/12 (8.3) | |||
| Site 3 | Bifrontal: 1/5 (20.0) | Bifrontal: 1/10 (10.0) | 4/5 (80.0) | 9/10 (90.0) |
| Bitemporal: 0 | Bitemporal: 2/10 (20.0) | |||
| Right unilateral: 0 | Right unilateral: 0 | |||
| Ultrabrief: 1/5 (20.0) | Ultrabrief: 2/10 (20.0) | |||
| Other: 3/5 (60.0) | Other: 5/10 (50.0) | |||
| Site 4 | Bifrontal: 16/32 (50.0) | Bifrontal: 14/31 (45.2) | 32/32 (100) | 29/30 (96.7) |
| Bitemporal: 8/32 (25.0) | Bitemporal: 3/31 (9.7) | |||
| Right unilateral: 0 | Right unilateral: 3/31 (9.7) | |||
| Ultrabrief: 8/32 (25.0) | Ultrabrief: 11/31 (35.5) | |||
| Site 5 | Bifrontal: 5/15 (33.3) | Bifrontal: 13/24 (54.2) | 15/15 (100) | 22/23 (95.7) |
| Bitemporal: 0 | Bitemporal: 0 | |||
| Right unilateral: 6/15 (40.0) | Right unilateral: 9/24 (37.5) | |||
| Ultrabrief: 4/15 (26.7) | Ultrabrief: 2/24 (8.3) | |||
| CARE Network total | Bifrontal: 44/97 (45.4) | Bifrontal: 57/98 (58.2) | 79/97 (81.4) | 86/94 (91.5) |
| Bitemporal: 8/97 (8.2) | Bitemporal: 6/98 (6.1) | |||
| Right unilateral: 11/97 (11.3) | Right unilateral: 14/98 (14.3) | |||
| Ultrabrief: 31/97 (32.0) | Ultrabrief: 16/98 (16.3) | |||
| Other: 3/97 (3.1) | Other: 5/98 (5.1) | |||
Acute ECT is defined as patients given ECT 2 or 3 times per week.
*Inconsistencies in numbers across variables within the same site due to missing data.